Gramiak R., Shah PM, Kramer DH: Ultrasound cardiography: Contrast studies in anatomy and function. Radiology92:939-948, 1969
2.
McKay RS, Rubssow G.: Decompression studies using ultrasonic imaging of bubbles. IEEE Trans BME25:537-544, 1978
3.
Ziskin MW, Bonakdarpour A., Wienstein DP, et al: Contrast agents for diagnostic ultrasound. Invest Radiol7:500-505, 1972
4.
Meltzer RS, Tickner EG, Sahines T., et al: The source of ultrasound contrast effect. J Clin Ultrasound18:121-127, 1980
5.
Kemper AJ, O'Boyle JE, Cohen CA, et al: Hydrogen peroxide contrast echocardiography: Quantification in vivo of myocardial risk area during coronary occlusion and of the necrotic area remaining after myocardial reperfusion. Circulation70:309-317, 1984
6.
Grinstaff MW , Suslick KS: Air filled proteinaceous microbubbles: Synthesis of an echo-contrast agent. Proc Natl Acad Sci USA88:7708-7710, 1991
7.
Ophir J., Parker KJ: Contrast agents in diagnostic ultrasound. Ultrasound Med Biol15:319-333, 1989
8.
Bommer WJ, Shah PM, Allen H.: The safety of contrast echocardiography: Report of the committee on contrast echocardiography of the American Society of Echocardiography. J Am Coll Cardiol3:6-13, 1984
9.
Feinstein SB , Ten Cate FJ, Zwehl W., et al: Two-dimensional contrast echocardiography. I. In vitro development and quantitative analysis of echo contrast agents . J Am Coll Cardiol3:14-20. 1984
10.
Goldman ME, Mindich BP: Intraoperative cardioplegic contrast echocardiography for assessing myocardial perfusion during open heart surgery. J Am Coll Cardiol4:1029-1034, 1984
11.
Aronson S., Lee BK, Zaroff JG, et al: Myocardial distribution of cardioplegic solution after retrograde surgery in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg105:214-221, 1993
12.
Voci P., Bilotta F., Caretta Q.: Mechanisms of incomplete distribution of cardioplegic solution during coronary artery grafting. Anesthesiology79:904-912, 1993
13.
Quintilio C. , Voci P., Bilotta F., et al; Risk factors for incomplete distribution of cardioplegic solution during coronary artery grafting. J Thorac Cardiovasc Surg109:439-447, 1995
14.
Aronson S., Lee BK, Wiencek JG, et al: Assessment of myocardial perfusion during CABG surgery with two-dimensional transesophageal contrast echocardiography. Anesthesiology75:433-440, 1991
Villanueva FS, Spotnitz WD, Jayaweera AR, et al: On-line intraoperative quantitation of regional myocardial perfusion during coronary artery bypass graft operations with myocardial contrast two-dimensional echocardiography. J Thorac Cardiovasc Surg104:1524-1531, 1992
17.
Zaroff JG, Aronson S., Lee BK, et al: The relationship between immediate outcome after cardiac surgery, homogenous cardioplegia delivery, and ejection fraction. Chest106:38-45,1994
18.
Winketman J. , Aronson S., Young CJ, et al: Retrograde-delivered cardioplegia is not distributed equally to the right ventricular free wall and septum. J Cardiothorac Vase Anesth9:135-139, 1995
19.
Aronson S., Savage R., Fernandez A., et al: Detecting myocardial stunning during cardiac surgery with contrast echocardiography. J Am Coll Cardiol85A:712-716, 1995
20.
Marcus ML, Wilson RF, White CW: Methods of measurement of myocardial blood flow in patients: A critical review . Circulation76:245-253, 1987
21.
Feinstein SB , Lang RM, Dick C., et al: Contrast echocardiography during coronary arteriography in humans: Perfusion and anatomic studies. J Am Coll Cardiol11:59-65, 1988
22.
Cheirlf J., Zoghbi WA, Raizner AE, et al: Assessment of myocardial perfusion in humans by contrast echocardiography. I. Evaluation of regional coronary reserve by peak contrast intensity. J Am Coll Cardiol11:735-743, 1988
23.
Jayaweera AR , Matthew TL, Sklenar J., et al: Method for the quandtation of myocardial perfusion during myocardial contrast echocardiography. J Am Soc Echocardiogr3:91-98, 1990
24.
Lin YJ, Nanto S., Masuyama T., et al: Visualization of subendocardial myocardial ischemia with myocardial contrast echocardiography in humans. Circulation79:233-244, 1989
25.
Bleeker H., Shung K., Barnhart J.: Ultrasound characterization of Albunex, a new contrast agent. J Acoust Soc Am87:1792-17991,1990
26.
Barnhart J. , Levene J., Villapondo E., et al: Characteristics of Allunex: Air-filled albumin microspheres for echocardiography contrast enhancement. Invest Radiol25:S162-S164, 1990
27.
Feinstein SB , Cheirif J., Ten Cate FJ, et al: Safety and efficacy of a new transpulmonary ultrasound contrast agent: Initial multicenter clinical results. J Am Coll Cardiol16:316-324, 1990
28.
Geny B., Mettauer B., Muan B., et al: Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients. J Am Coll Cardiol22:1193-1198, 1993
29.
Keller MW, Glasheen W., Kaul S., et al: A safe and effective commercially produced agent for myocardial contrast echocardiography. J Am Soc Echocardiogr2:48-52, 1989
30.
Walker R., Wiencek JG, Aronson S., et al:The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity. J Arn Soc Echocardiogr5:463-470, 1992
31.
Feinstein SB , Shah PM, Bing RJ, et al: Microbubble dynamics visualized in the intact capillary circulation. J Am Coll Cardiol4:595-600, 1984
32.
Levine RA, Teichholtz LE, Goldman ME, et al: Microbubbles have intracardiac velocities similar to those of red blood cells. J Am Coll Cardiol3:28-33, 1984
33.
Jayaweera AR , Edwards N., Glasheen WP, et al: In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography: Comparison with radiolabeled red blood cells. Circ Res74:1157-1165, 1994
34.
Keller MW, Segal SS, Kaul S., et al: The behavior of sonicated albumin microbubbles within the microcirculation: A basis for their use during myocardial contrast echocardiography. Circ Res65:458-467, 1989
35.
Fritzsch T. , Hilmann J., Kampfe M., et al: SHU 508, a transpulmonary echocontrast agent: Initial experience. Invest Radiol25:S160-S161, 1990 (suppl)
36.
Smith MD, Elion JL, McClure RR, et al: Left heart opacification with peripheral venous injection of a new saccharide echo contrast agent in dogs. J Am Coll Cardiol13:1622-1628, 1989
37.
Heidelmeyer CF, Brueckner JB, Schartl M.: Myocardial contrast echocardiography: Cardiovascular effects of the contrast medium SHU 454 in dogs. J Cardiothorac Anesth4:60-67, 1990
38.
Camarano GP , Ismail S., Goodman NC, et al: Assessment of risk area during coronary occlusion and infarct size after reperfusion can be determined with myocardial contrast echocardiography using intravenous injections of FS-069, a new contrast agent. Circulation90:1-68, 1994 (abstr).
39.
Wiencek JG, Feinstein SB, Walker R., et al: Pitfalls in quantitative contrast echocardiography: The steps to quantitation of periusion. J Am Soc Echocardiogr6:395-416, 1993
40.
Feinstein SB, Voci P., Seigal L., et al: Contrast echocardiography, in Marcus ML, Schelbert HR, Skorton DJ: Cardiac Imaging: A Companion to Braurrwald's Heart Disease . Philadelphia, PA, Saunders, 1991, pp 557-574
41.
Heidenreich PA, Wiencek JG, Zaraff JG, et al: In vitro calculation of flow by use of contrast echocardiography. J Am Soc Echocardiogr6:51-61, 1993
42.
Aronson S., Wiencek JG, Feinstein SB, et al: Assessment of renal blood flow with contrast ultrasonography . Anesth Analg76:964-970, 1993
43.
de Jong N., Ten Cate FJ, Lancee CT, et al: Principles and recent developments in ultrasound contrast agents . Ultrasonics29:324-330, 1991
44.
Menasche P., Piwnica A.: Cardioplegia by way of the coronary sinus for valvular and coronary surgery . J Am Coll Cardiol18:628-636, 1991
45.
Partington MT, Acar C., Buckberg GD, et al: Studies of retrograde cardioplegia. I. Capillary blood flow distribution to myocardium supplied by open and occluded arteries. J Thorac Cardiovasc Surg97:605-612, 1989
Buckberg GD : Antegrade/retrograde blood cardioplegia to ensure cardioplegic distribution: Operative techniques and objectives. J Card Surg4:216-238. 1989
48.
Grundry SR, Kirsch MM: A comparison of retrograde cardioplegia versus antegrade in the presence of coronary artery obstruction. Ann Thorac Surg38:124-127, 1984
49.
Kaul S., Glasheen WP, Ruddy TD, et al: The importance of defining left ventricular area at risk in-vivo during acute myocardial infarction: An experimental evaluation with myocardial contrast two-dimensional echocardiography. Circulation75:1249-1260, 1987
50.
Aronson S., Bender EM, Feinstein SB, et al: Contrast echocardiography: A method to visualize changes in regional myocardial perfusion in a dog model for CABG surgery. Anesthesiology72:295-301, 1990
51.
Aronson S., Lee BK, Liddicoat JR, et al: Assessment of retrograde cardioplegia distribution using contrast echocardiography. Ann Thorac Surg52:810-814, 1991
52.
Stirling MC , McClanahan TB, Schott RJ, et al: Distribution of cardioplegic solution infused antegradely and retrogradely in normal canine hearts. J Thorac Cardiovasc Surg98:1066-1076, 1989
53.
Caretta Q., Voci P., Bilotta F., et al: Intraoperative detection of coronary artery graft occlusion by myocardial contrast echocardiography. J Cardiothorac Vase Anesth8:206-208, 1994
54.
Lim YJ, Nanto S., Masuyama T. et al: Coronary collaterals assessed with myocardial contrast echocardiography in healed myocardial infarction. Am J Cardiol66:556-561, 1990
55.
Spotnitz WD , Matthew TL, Keller MW, et al: Intraopcrative demonstration of coronary collateral flow using myocardial contrast two-dimensional echocardiography . Am J Cardiol15:1259-1261, 1990
56.
Dent JM, Jayaweera AR, Glasheen WP, et al: Amathematical model for the quantification of mitral regurgitation: Experimental validation in the canine model using contrast echocardiography . Circulation86:553-562, 1992
57.
Cheirif J., Zoghbi WA, Bolli R., et al: Assessment of regional myocardial perfusion by contrast echocardiography. II. Detection of changes in transmural and subendocardial perfusion during dypyridamole-induced hyperemia in a model of critical coronary stenosis. J Am Coll Cardiol14:1555-1565, 1989
58.
Sabia PJ, Powers ER, Ragosta M., et al: An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med327:1825-1831, 1992
59.
Bolli R.: Myocardial "stunning" in man. Circulation86:1671-1691, 1992
60.
Aronson S., Young C., Fernandez A., et al: Assessing myocardial perfusion during CABG surgery with Albunex: Safety and efficacy. Anesthesiology81:A171, 1994 (abstr)
61.
Villanueva F., Glasheen W. Sklenar J, et al: Successful and reproducible myocardial opacification during two-dimensional echocardiography from right heart injection of contrast. Circulation85:1537-1567, 1992
